Emergent Biosolutions Inc
EBS
Market Cap$307M
Close$
$0.90
84.7% downside
Current Fair Value
84.7% downsideOvervalued by 84.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $307.00 Million |
|---|---|
| Enterprise Value | $871.20 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.6 |
| Beta | 2.09 |
| Outstanding Shares | 54,200,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.61 |
|---|---|
| PEG | 1.12 |
| Price to Sales | 0.28 |
| Price to Book Ratio | 0.74 |
| Enterprise Value to Revenue | 0.76 |
| Enterprise Value to EBIT | 8.52 |
| Enterprise Value to Net Income | 10 |
| Total Debt to Enterprise | 0.76 |
| Debt to Equity | 1.37 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Emergent Biosolutions Inc
CEO: Robert Kramer